Clinical Trial Update: GU-01: Glycyrrhizin in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for glycyrrhizin (GU-01) in prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Glycyrrhizin (GU-01) (glycyrrhizin)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING